Sector: Life Science
Client requirement
In the dynamic landscape of biopharmaceuticals, our client, a global vaccine leader, embarked on a transformative journey with the strategic implementation of a Working Capital Reduction Program. This program was meticulously designed to optimize the inventory of direct materials.
Challenges
Navigating the delicate balance between inventory optimization and maintaining production stability presented significant challenges. The adoption of these strategies across diverse planning teams, where production parameters held sway, required a nuanced approach. Bridging the perspectives of senior leadership with daily shop floor operations added another layer of complexity.
Approach
Our innovative solutions included:
Establishment of a central planning department to streamline efforts.
Rollout of an extensive inventory optimization program.
Introduction of diverse analytical tools for enhanced decision-making.
Development of a comprehensive inventory management philosophy and associated policies.
Results
The collaborative efforts yielded remarkable results:
Achieved an impressive 18% reduction in working capital on average for direct materials used in EU sites, showcasing the success of the Working Capital Reduction Program
Harmonized the inventory management policy across the organization, ensuring a consistent and efficient approach to inventory optimization.
Moore Expertise
The Moore Supply Chain team thrives on crafting success stories. This customer case exemplifies our expertise in optimizing Material Requirements Planning (MRP) and enhancing inventory management for industry leaders. Contact us to explore how we can tailor solutions for your organization's success.